Diabetes, Insufficient blood perfusion, diabetic foot ulcers, cardiovascular disease, peripheral artery disease, stroke, clinical development, formulations of FGF-1, medical indications, active drug development programs, vascular disorders in the brain, vascular disorders feet, vascular disorders heart, Regeneration of new blood vessels via angiogenesis, Regeneration of new blood, angiogenesis, blood vessels in the body, growth factors, stimulate new vessel growth, Insufficient blood perfusion, peripheral artery disease, stroke, therapeutic angiogenesis, unnecessary amputations, Perfusion, cardiovascular health, optimal perfusion. Ischemia, blood flow interrupted, coronary arteries, coronary artery disease, myocardial ischemia, Chest pain, angina, myocardial cells, prolonged ischemia, prolonged ischemia of heart tissue, necrosis, poor circulation, and oxygen-starved hearts, therapeutic angiogenesis, Fibroblast growth factor 1 (FGF-1) potent angiogenic agent, Fibroblast growth factor, growth factors, stimulate angiogenesis, production capillaries, production capillaries arterioles, FGF cell surface receptor, Diabetic foot ulcers, Venous leg ulcers, Stroke, Vascular Dementia, multi-infarct dementia, lack of blood perfusion results, blood brain barrier, IV infusions, Alzheimer’s Disease, degeneration in the microvasculature of the brain, neurofibrillary tangles, Coronary Artery Disease, Dan Montano, Zhittya Regenerative Medicine, life-saving drugs, Jack Jacobs, Ph.D., President and Chief Scientific Officer, Davidson College, Washington University, St. Louis,Viktoriya Tamlenova-Montano, Vice President of Strategic Innovation, heavy industry detailing and construction from Kiev College of Electric Engineering, Construction and Industrial Design Kiev State University of Civil Engineering and Architecture, Kiev State University of Civil Engineering and Architecture, Canada, South East Asia, Latin America, China, India, Korea, Japan, South-East Asia, India, Korea, Japan and Australia, New Zealand, Las Vegas, Las Vegas Nevada, biotechnology, biopharmaceuticals, wound healing biotherapeutics, wound healing

Developing healthier lives for the world


For more information contact us today.

October 14, 2020: 

Can Therapeutic Angiogenesis Extend Your Life an Additional 30 Quality Years?

Click Image Above to See More Videos

Zhittya Webinars

September 15, 2020: 

Can Therapeutic Angiogenesis Extend Your Life an Additional 30 Quality Years?

August 20, 2020: 

Diabetic Foot Ulcers: Is Angiogenesis a Possible Treatment or Even a Cure?

November 18, 2020: 

Heart Disease, Stroke, Parkinson's Disease:

September 15, 2020: 

Multiple Sclerosis: Is Therapeutic Angiogenesis a Possible Treatment?

September 29, 2020: 

Parkinson's Disease Webinar- Is Angiogenesis A Possible Treatment?

Zhittya Genesis Medicine, Inc.

November 23, 2020: 

Multiple Sclerosis

September 22, 2020: 

Chronic Depression- Is Angiogenesis a Possible Treatment or Even a Cure.

See More Zhittya Webinars on YouTube

October 29, 2020: 

AlS: Is Therapeutic Angiogenesis a Possible Treatment or Even a Cure?